Jackson C A, Insel P A
Department of Pharmacology, University of California, San Diego, La Jolla 92093-0636.
Pediatr Nephrol. 1993 Dec;7(6):853-8. doi: 10.1007/BF01213373.
The hypothesis has been proposed that an increase in the number of renal alpha-adrenergic receptors may contribute to the pathogenesis of genetic hypertension. Herein we review recent findings regarding expression of renal alpha 1 (alpha 1a, alpha 1b)- and alpha 2 (alpha 2a, alpha 2b)-adrenergic subtypes and we provide an updated revision of the above-stated hypothesis. Enhancement in receptor number or in post-receptor components responsible for alpha 1- and alpha 2-adrenergic-mediated sodium reabsorption in proximal tubule may contribute to sodium retention and an elevation in blood pressure. Perhaps such changes contribute to the increase in blood pressure in genetically determined hypertension in humans, although direct tests of this notion have not yet been performed.
有人提出假说,认为肾α-肾上腺素能受体数量增加可能与遗传性高血压的发病机制有关。在此,我们综述了有关肾α1(α1a、α1b)-和α2(α2a、α2b)-肾上腺素能亚型表达的最新研究结果,并对上述假说进行了更新。受体数量的增加或负责近端小管中α1-和α2-肾上腺素能介导的钠重吸收的受体后成分的增强,可能导致钠潴留和血压升高。尽管尚未对这一观点进行直接验证,但这些变化可能导致人类遗传性高血压患者血压升高。